Jiangsu Jibeier Pharmaceutical Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 257.21 million compared to CNY 250.8 million a year ago. Revenue was CNY 257.21 million compared to CNY 250.8 million a year ago.

Net income was CNY 42.11 million compared to CNY 55.65 million a year ago. Basic earnings per share from continuing operations was CNY 0.23 compared to CNY 0.3 a year ago. Diluted earnings per share from continuing operations was CNY 0.23 compared to CNY 0.3 a year ago.